Dean Capital Investments Management »

Tscan Therapeutics shares owned by Dean Capital Investments Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Dean Capital Investments Management from 13F filings

Historical chart of Dean Capital Investments Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Dean Capital Investments Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Dean Capital Investments Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $91k 36k 2.56
2023-06-30 $89k 36k 2.50
2023-03-31 $75k 36k 2.10
2022-12-31 $55k 36k 1.55
2022-09-30 $110k 36k 3.09
2022-06-30 $112k 36k 3.15
2022-03-31 $100k 36k 2.81
2021-12-31 $160k 36k 4.50
2021-09-30 $297k 36k 8.35